Article Topic:  Emily L. Podany, MD, MPHS

Podany Named to Inaugural NCCN Advocacy Academy

WashU Medicine physician-scientist Emily L. Podany, MD, MPHS, has been selected for a new fellowship program that aims to connect people on the front lines of cancer care to share their knowledge and experience with federal policymakers.

Launched by the National Comprehensive Cancer Network (NCCN), the Advocacy Academy aims to provide oncology fellows and junior faculty at NCCN member institutions with advocacy skills and training to champion policies that will improve the lives of those affected by cancer.



Podany is an assistant professor of medicine at WashU Medicine and a medical oncologist who treats patients diagnosed with breast cancer at Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine.

Her selection highlights her leadership at the intersection of cancer care and public policy. As part of this inaugural fellowship, she will focus on a critical regional and national issue: improving education around cancer risks linked to Coldwater Creek in north St. Louis County and helping affected individuals navigate the newly expanded Radiation Exposure Compensation Act (RECA).

Through the program, Podany will participate in policy education sessions, receive mentorship from national experts, and collaborate with congressional offices to advance meaningful cancer policy reform.

In addition to this recognition, Podany was also recently named a 2026 Young Investigator Award recipient, further underscoring her commitment to improving cancer care, particularly for patients facing social and structural barriers. Her research focuses on implementing navigation interventions for breast cancer patients with high-risk social determinants of health.

The NCCN is a nonprofit alliance of 33 cancer centers, including Siteman Cancer Center, that is dedicated to improving the quality and effectiveness of cancer care, research and education.

NCCN Recognizes Podany as 2026 Young Investigator Award Recipient

WashU Medicine physician-scientist Emily L. Podany, MD, MPHS, has been named a 2026 recipient of a prestigious NCCN Foundation Young Investigator Award, given by the National Comprehensive Cancer Network (NCCN) and NCCN Foundation.

Podany is an assistant professor of medicine at WashU Medicine and a medical oncologist who treats patients diagnosed with breast cancer at Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine.

She is being recognized for her research project, titled “From Screening to Action: Implementing Navigation Interventions for Patients with Breast Cancer and High-Risk Social Determinants of Health.” Her work focuses on addressing barriers that can prevent patients from receiving timely and effective cancer care, particularly among populations facing social and economic challenges.

Through this award, Podany will receive funding and support from the NCCN Oncology Research Program over two years. The program provides mentorship and oversight to help early-career investigators advance innovative research aimed at improving cancer outcomes.

“We have a rigorous peer review process for identifying emerging leaders in cancer research through their work,” said Crystal S. Denlinger, MD, CEO, NCCN. “NCCN Young Investigators go on to lead within their institutions and nationally. This year’s recipients identified particularly pressing needs that impact people with cancer. They are exploring solutions to unlock better outcomes for all in the future. We are honored to play a role in their career trajectory and look forward to seeing where it takes them.”

Podany is one of five early-career researchers to be recognized this year. Her project is designed to move beyond identifying patients at risk to actively connecting them with the care and resources they need. By developing targeted patient navigation interventions, she aims to further reduce delays in diagnosis and treatment and improve care coordination, ultimately ensuring that patients with breast cancer receive equitable, timely and high-quality care.

“I am deeply grateful to the NCCN Foundation for this support,” Podany said. “This award will allow us to take meaningful steps toward ensuring that patients facing social and economic challenges are not left behind in their cancer care. Our goal is to translate screening for social determinants of health, such as food insecurity and housing instability, into tangible action by connecting patients to the resources they need to achieve the best possible outcomes.”

Podany’s work reflects the broader mission of the NCCN Foundation to support innovative research that addresses disparities in cancer care and improves outcomes for all patients. Her focus on practical, patient-centered interventions highlights the importance of bridging gaps between diagnosis and treatment. She will present her work at the NCCN 2029 Annual Conference.

The NCCN is a nonprofit alliance of 33 cancer centers, including Siteman Cancer Center, that is dedicated to improving the quality and effectiveness of cancer care, research and education.